As the number of immunocompromised patients rise in our hospitals, the presentation of severe infections caused by HSV and CMV are rising. Most importantly, lack of response and documented resistance are becoming more frequently observed.
Topics discussed:This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at aac.asm.org. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/membership to sign up.
Visit journals.asm.org/journal/aac to browse issues and/or submit a manuscript.
Training in Antimicrobial Resistance: Gaps and Opportunities
10 Years of Rhodococcus: Clinical Trends and Susceptibility Profiles
Why Phage Therapy May Fail
Is Lophomonas a Pathogen?
Treatment of Multidrug-resistant Tuberculosis
New generation B-lactam/B-lactamase inhibitors: Taniborbactam
Favorite Clinical Microbiology Papers of 2023 (JCM ed.)
Antimicrobial Resistance in Neisseria Gonorrhoeae (JCM ed.)
New Antifungals (AAC ed.)
A Novel Coccidioides Antibody LFA (JCM ed.)
Climate Change and Antimicrobial Resistance (AAC ed.)
Emerging Antifungal-Resistant Dermatophytes (JCM ed.)
Artificial Intelligence and Infectious Diseases (AAC ed.)
Viral Outbreaks in the Headlines (JCM ed.)
AAC Launches a New Section Focused On Antimicrobial Stewardship (AAC ed.)
Susceptibility Testing for Aztreonam with Ceftazidime-Avibactam (JCM ed.)
Hispanic Leadership in Vaccine Sciences With Dr. Maria Elena Bottazzi (AAC ed.)
Updates on Testing for Vaginitis/Vaginosis (JCM ed.)
Susceptibility Testing for Piperacillin-Tazobactam (JCM ed.)
Create your
podcast in
minutes
It is Free
This Week in Virology
This Week in Microbiology
This Week in Parasitism
Meet the Microbiologist
MicrobeWorld Video (audio only)